Skip to navigation bar Skip to breadcrumbs Skip to page content Skip to comments area
clear place holder
Envelope icon E-mail Updates Teal square Text size:  a A A
You are here: HomePublic Comments and NominationsOpportunity for Public CommentDraft Evidence Review : Draft Contextual Review: Overdiagnosis in Prostate Cancer Screening Decision Models

Draft Contextual Review: Overdiagnosis in Prostate Cancer Screening Decision Models

Draft Evidence Review for Prostate Cancer: Screening

This opportunity for public comment expired on May 8, 2017 at 8:00 PM EST

Note: This is a Draft Evidence Review. This draft is distributed solely for the purpose of receiving public input. It has not been disseminated otherwise by the USPSTF. The final Evidence Review will be used to inform the USPSTF Recommendation Statement on this topic.

Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

Send Us Your Comments

In an effort to maintain a high level of transparency in our methods, we open our draft Evidence Reviews to a public comment period before we publish the final version.

Comment period is not open at this time.

For more information on the draft recommendation on screening for prostate cancer, go to www.screeningforprostatecancer.org.

Overdiagnosis in Prostate Cancer Screening Decision Models (PDF File, 470 KB; PDF Help)

Persons using assistive technology may not be able to fully access information in this PDF file. For assistance, contact Lisa Nicolella at (301) 427-1906 or lisa.nicolella@ahrq.hhs.gov.

Current as of: April 2017

Internet Citation: Draft Evidence Review: Prostate Cancer: Screening. U.S. Preventive Services Task Force. April 2017.
https://www.uspreventiveservicestaskforce.org/Page/Document/draft-contextual-review-2/prostate-cancer-screening1

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857